Ursa Fund Management’s Checkpoint Therapeutics CKPT Stock Holding History

Ursa Fund Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,000	Closed	-$404K	–	33
2025 Q1	$404K	Buy	+100,000	New	+$333K	1.04%	13

Ursa Fund Management's CKPT Position: Q2 2025 in Review

Ursa Fund Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 100,000 shares — an estimated $404K sold.

Ursa Fund Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $404K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Ursa Fund Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Ursa Fund Management sold 100,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $404K.
Ursa Fund Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Ursa Fund Management's Checkpoint Therapeutics position peaked at $404K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Ursa Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.